Skip to main content
Home
  • Company
    • History
    • Leadership
    • Clients and Collaborators
    • By the Numbers
  • Capabilities
    • Emmes - CRO
      • Specialties
        • Vaccines & Infectious Diseases
        • Ophthalmology
        • Clinical Neuroscience
        • Rare Disease
        • Cell & Gene Therapy
        • Government
      • Additional Specialties
        • Hematology
        • Oncology
        • Maternal & Child Health
        • Medical Devices
      • Clinical Services
        • Biostatistics
        • Clinical Data Management
        • Clinical Research Services
        • Clinical Trial Management
        • Global Regulatory Affairs
        • Pharmacovigilance & Medical Monitoring
    • Veridix - Tech & AI
      • eClinical Platform
        • EDC
        • Decentralized Clinical Trials
        • Health Navigator
        • RTSM
        • eCOA / ePRO
      • AI Agents
        • Biostats and Analysis Agent
        • Data Management Agent
        • Document Authoring
      • GlobalTrace
      • Analytics & Reporting
        • Clinical Pipelines
        • VERA
  • Resources
    • Newsroom
    • Blog
  • Careers
  • Contact
    • Locations
    • Contact Us

Breadcrumb

  1. Emmes Group

Intrarenal expression of cytotoxic attack molecules during acute rejection of renal allografts in pediatric recipients.

Go back to Resources

Intrarenal expression of cytotoxic attack molecules during acute rejection of renal allografts in pediatric recipients.

Authors:

Location:

Go back to Resources

Immune responses to human immunodeficiency virus (HIV) type 1 induced by canarypox expressing HIV-1MN gp120, HIV-1SF2 recombinant gp120, or both vaccines in seronegative adults

Go back to Resources

Immune responses to human immunodeficiency virus (HIV) type 1 induced by canarypox expressing HIV-1MN gp120, HIV-1SF2 recombinant gp120, or both vaccines in seronegative adults

Authors:

Secondary:

Volume:

Pagination:

Go back to Resources

History of clinical trials

Go back to Resources

History of clinical trials

Authors:

Secondary:

Location:

Publisher:

Go back to Resources

Growth post-renal transplantation in children: 11 year North American Pediatric Renal Transplant Cooperative Study (NAPRTCS) report.

Go back to Resources

Growth post-renal transplantation in children: 11 year North American Pediatric Renal Transplant Cooperative Study (NAPRTCS) report.

Authors:

Location:

Go back to Resources

For the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS): The impact of donor source, pre-operative immunotherapy and prophylactic antibody therapy on first rejection episodes in children.

Go back to Resources

For the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS): The impact of donor source, pre-operative immunotherapy and prophylactic antibody therapy on first rejection episodes in children.

Authors:

Location:

Go back to Resources

For the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS): Quality of life of children post-transplantation compared to children on dialysis.

Go back to Resources

For the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS): Quality of life of children post-transplantation compared to children on dialysis.

Authors:

Location:

Go back to Resources

Fecal occult blood screening in the Minnesota Study. Letter

Go back to Resources

Fecal occult blood screening in the Minnesota Study. Letter

Authors:

Secondary:

Volume:

Pagination:

Go back to Resources

Effect of parental donor sex on rejection in pediatric renal transplantation: A report of the North American Pediatric Cooperative Study (NAPRTCS)

Go back to Resources

Effect of parental donor sex on rejection in pediatric renal transplantation: A report of the North American Pediatric Cooperative Study (NAPRTCS)

Authors:

Secondary:

Volume:

Pagination:

Go back to Resources

Dramatic improvement in cadaver donor graft survival of North American children.

Go back to Resources

Dramatic improvement in cadaver donor graft survival of North American children.

Authors:

Go back to Resources

Development and valuation of a food frequency questionnaire in a randomized trial of eye diseases.

Go back to Resources

Development and valuation of a food frequency questionnaire in a randomized trial of eye diseases.

Authors:

Location:

Go back to Resources

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 109
  • Page 110
  • Page 111
  • Page 112
  • Current page 113
  • Page 114
  • Page 115
  • Page 116
  • Page 117
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to
Emmes Group

Delivering Global Health
Impact Through People,
Science and Technology

Main navigation
  • Company
    • History
    • Leadership
    • Clients and Collaborators
    • By the Numbers
  • Capabilities
    • Emmes - CRO
    • Veridix - Tech & AI
  • Resources
    • Newsroom
    • Blog
  • Careers
  • Contact
    • Locations
    • Contact Us
linkedin X

Copyright ©, The Emmes Company, LLC

Footer
  • Cookie Policy
  • External Privacy Notice
  • FCOI
  • Emmes EU-U.S. Data Privacy Framework
  • Purchasing Terms and Conditions

Cookie Policy

Our site uses cookies for analytics and to improve our site and services. You can manage these cookies via your browser settings at any time. By continuing to use our site, you agree to our use of cookies. For more information, including how to change your settings, see our Cookie Policy.